Current strategies for DNA therapy based on lipid nanocarriers

Bibliography

• Peng Z. Current status of gendicine in china: Recombinant human ad-p53 agent for treatment of cancers. Hum Gene Ther 2005;16:1016-27
   PubMed Web of Science ®Google Scholar
• Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4:346-58
   PubMed Web of Science ®Google Scholar
• Duncan R, Gaspar R. Nanomedicine(s) under the microscope. Mol Pharm 2011;8:2101-41
   PubMed Web of Science ®Google Scholar
• Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem Rev 2009;109:259-302
   PubMed Web of Science ®Google Scholar
• Guo X, Huang L. Recent advances in nonviral vectors for gene delivery. Acc Chem Res 2012;45:971-9
   PubMed Web of Science ®Google Scholar
• Svenson S, Tomalia DA. Dendrimers in biomedical applications – reflections on the field. Adv Drug Deliv Rev 2005;57:2106-29
   PubMed Web of Science ®Google Scholar
• Lalatsa A, Schätzlein AG, Mazza M, et al. Amphiphilic poly (l-amino acids) – New materials for drug delivery. J Control Release 2012;161:523-36
   PubMed Web of Science ®Google Scholar
• Safinya CR. Structures of lipid–DNA complexes: supramolecular assembly and gene delivery. Curr Opin Struct Biol 2001;11:440-8
   PubMed Web of Science ®Google Scholar
• Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413-17
   PubMed Web of Science ®Google Scholar
• Zhang S, Xu Y, Wang B, et al. Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release 2004;100:165-80
   PubMed Web of Science ®Google Scholar
• Mosca M, Ceglie A, Ambrosone L. Effect of membrane composition on lipid oxidation in liposomes. Chem Phys Lipids 2011;164:158-65
   PubMed Web of Science ®Google Scholar
• Chen J, Yu Z, Chen H, et al. Transfection efficiency and intracellular fate of polycation liposomes combined with protamine. Biomaterials 2011;32:1412-18
   PubMed Web of Science ®Google Scholar
• Farhood H, Serbina N, Huang L. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim Biophys Acta BBABiomembr 1995;1235:289-95
   PubMed Web of Science ®Google Scholar
• Moghaddam B, McNeil SE, Zheng Q, et al. Exploring the correlation between lipid packaging in lipoplexes and their transfection efficacy. Pharmaceutics 2011;3:848-64
   PubMedGoogle Scholar
• Felgner JH, Kumar R, Sridhar CN, et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994;269:2550-61
   PubMed Web of Science ®Google Scholar
• Hunt KK, Vorburger SA. Hurdles and hopes for cancer treatment. Science 2002;297:415-16
   PubMed Web of Science ®Google Scholar
• Crook K, Stevenson BJ, Dubouchet M, Porteous DJ. Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum. Gene Ther 1998;5:137-43
   PubMed Web of Science ®Google Scholar
• Zhang Y, Anchordoquy TJ. The role of lipid charge density in the serum stability of cationic lipid/DNA complexes. Biochim Biophys Acta 2004;1663:143-57
   PubMed Web of Science ®Google Scholar
• Bertrand N, Leroux J. The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release 2012;161:152-63
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009;61:428-37
   PubMed Web of Science ®Google Scholar
• Zahr AS, Davis CA, Pishko MV. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 2006;22:8178-85
   PubMed Web of Science ®Google Scholar
• Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol 2005;18:209-19
   PubMed Web of Science ®Google Scholar
• Kaur IP, Garg A, Singla AK, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm 2004;269:1-14
   PubMed Web of Science ®Google Scholar
• Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol Sci 1994;15:215-20
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomedicine 2006;1:297
   PubMed Web of Science ®Google Scholar
• Namiki Y, Fuchigami T, Tada N, et al. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Acc Chem Res 2011;44:1080-93
   PubMed Web of Science ®Google Scholar
• Lasic D, Templeton N. Liposomes in gene therapy. Adv Drug Deliv Rev 1996;20:221-66
   Web of Science ®Google Scholar
• Igarashi S, Hattori Y, Maitani Y. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Control Release 2006;112:362-8
   PubMed Web of Science ®Google Scholar
• Woodle MC, Scaria P. Cationic liposomes and nucleic acids. Curr Opin Colloid Interface Sci 2001;6:78–84
   Web of Science ®Google Scholar
• Igarashi S, Hattori Y, Maitani Y. Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Control Release 2006;112:362–8
   PubMed Web of Science ®Google Scholar
• Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 2006;116:255-64
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li H, Sun J, et al. DC-chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. Int J Pharm 2010;390:198-207
   PubMed Web of Science ®Google Scholar
• Li S, Rizzo MA, Bhattacharya S, Huang L. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery. Gene Ther 1998;5:930-7
   PubMed Web of Science ®Google Scholar
• Mével M, Kamaly N, Carmona S, et al. DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. J Control Release 2010;143:222-32
   PubMed Web of Science ®Google Scholar
• Yang S, Zheng Y, Chen J, et al. Comprehensive study of cationic liposomes composed of DC-chol and cholesterol with different mole ratios for gene transfection. Colloids Surf B, Biointerfaces 2013;101:6-13
   PubMed Web of Science ®Google Scholar
• Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther 1997;4:961-8
   PubMed Web of Science ®Google Scholar
• Chen J, Sun X, Yu Z, et al. Influence of lipid components on gene delivery by polycation liposomes: transfection efficiency, intracellular kinetics and in vivo tumor inhibition. Int J Pharm 2012;422:510-15
   PubMed Web of Science ®Google Scholar
• Endo-Takahashi Y, Negishi Y, Nakamura A, et al. pDNA-loaded bubble liposomes as potential ultrasound imaging and gene delivery agents. Biomaterials 2013;34:2807-13
   PubMed Web of Science ®Google Scholar
• Souto E, Almeida A, Muller R. Lipid nanoparticles (SLN, NLC) for cutaneous drug delivery: structure, protection and skin effects. J Biomed Nanotechnol 2007;3:317-31
   Web of Science ®Google Scholar
• Muchow M, Maincent P, Müller RH. Lipid nanoparticles with a solid matrix (SLN®, NLC®, LDC®) for oral drug delivery. Drug Dev Ind Pharm 2008;34:1394-405
   PubMed Web of Science ®Google Scholar
• Freitas C, Muller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. Eur J Pharm Biopharm 1999;47:125-32
   PubMed Web of Science ®Google Scholar
• Joshi MD, Müller RH. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 2009;71:161-72
   PubMed Web of Science ®Google Scholar
• Kumar S, Randhawa JK. High melting lipid based approach for drug delivery: solid lipid nanoparticles. Mater Sci Eng C Mater Biol Appl 2013;33:1842-52
   PubMed Web of Science ®Google Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54(Suppl 1):S131-55
   PubMed Web of Science ®Google Scholar
• del Pozo-Rodríguez A, Delgado D, Solinís M, et al. Solid lipid nanoparticles: formulation factors affecting cell transfection capacity. Int J Pharm 2007;339:261-8
   PubMed Web of Science ®Google Scholar
• Basaran E, Demirel M, Sirmagül B, Yazan Y. Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 2010;27:37-47
   PubMed Web of Science ®Google Scholar
• Li X, Nie S, Kong J, et al. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008;363:177-82
   PubMed Web of Science ®Google Scholar
• del Pozo-Rodriguez A, Delgado D, Solinís M, et al. Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. Int J Pharm 2008;360:177-83
   PubMed Web of Science ®Google Scholar
• del Pozo-Rodríguez A, Solinís M, Gascón A, Pedraz J. Short-and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm 2009;71:181-9
   PubMed Web of Science ®Google Scholar
• del Pozo-Rodriguez A, Delgado D, Solinis MA, et al. Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration. Int J Pharm 2010;385:157-62
   PubMed Web of Science ®Google Scholar
• Vighi E, Ruozi B, Montanari M, et al. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles. Int J Pharm 2010;389:254-61
   PubMed Web of Science ®Google Scholar
• Delgado D, Gascón AR, del Pozo-Rodríguez A, et al. Dextran–protamine–solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice. Int J Pharm 2012;425:35-43
   PubMed Web of Science ®Google Scholar
• Thanou M, Verhoef JC, Junginger HE. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev 2001;50(Suppl 1):S91-S101
   PubMed Web of Science ®Google Scholar
• Delgado D, del Pozo-Rodríguez A, Angeles Solinís M, et al. New gene delivery system based on oligochitosan and solid lipid nanoparticles: ‘in vitro’ and ‘in vivo’ evaluation. Eur J Pharm Sci 2013;50:484-91
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310-16
   PubMed Web of Science ®Google Scholar
• Zorzi GK, Párraga JE, Seijo B, Sánchez A. Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy. Macromol Biosci 2011;11:905-13
   PubMed Web of Science ®Google Scholar
• Puri A, Loomis K, Smith B, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst 2009;26:523-80
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60
   PubMed Web of Science ®Google Scholar
• Zhang L, Chan JM, Gu FX, et al. Self-assembled lipid – polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2008;2:1696-702
   PubMed Web of Science ®Google Scholar
• Chan JM, Zhang L, Yuet KP, et al. PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery. Biomaterials 2009;30:1627-34
   PubMed Web of Science ®Google Scholar
• Hoarau D, Delmas P, David S, et al. Novel long-circulating lipid nanocapsules. Pharm Res 2004;21:1783-9
   PubMed Web of Science ®Google Scholar
• Li J, He YZ, Li W, et al. A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacol Sin 2010;31:509-14
   PubMed Web of Science ®Google Scholar
• Zhong Q, Chinta D, Pamujula S, et al. Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes. J Nanobiotechnology 2010;8:6
   PubMedGoogle Scholar
• Fang RH, Aryal S, Hu CJ, Zhang L. Quick synthesis of lipid − polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir 2010;26:16958-62
   PubMed Web of Science ®Google Scholar
• Yuan H, Zhang W, Du Y, Hu F. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery. Int J Pharm 2010;392:224-31
   PubMed Web of Science ®Google Scholar
• Zhang Z, Fang X, Hao J, et al. Triolein-based polycation lipid nanocarrier for efficient gene delivery: characteristics and mechanism. Int J Nanomedicine 2011;6:2235-44
   PubMed Web of Science ®Google Scholar
• Sanchez A, Seijo B, Pensado A. Nanoparticles based on sorbitan esters. 2013. Available from: http://www.youtube.com/watch?v=fda9CtJ5zF0
   Google Scholar
• Sanchez A, Seijo B, Zorzi GK, et al. Nanoparticulate systems prepared from sorbitan esters. WO2013068625A1; 2013
   Google Scholar
• Pensado A, Seijo B, De La Cerda B, et al. Span nanoparticles as more efficient vectors for in vivo transfection of photoreceptors and RPE cells than adeno-associated viral vectors. 41st Annual Meeting & Exposition of the Controlled Release Society. 13 – 16 July 2014; Chicago
   Google Scholar
• The Journal of Gene Medicine. http://www.wiley.com//legacy/wileychi/genmed/clinical/ [Accessed 22 October 2013]
   Google Scholar